vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Honest Company, Inc. (HNST). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($88.0M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). Honest Company, Inc. runs the higher net margin — -26.8% vs -70.9%, a 44.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -11.8%). Honest Company, Inc. produced more free cash flow last quarter ($18.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 1.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
CTKB vs HNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $88.0M |
| Net Profit | $-44.1M | $-23.6M |
| Gross Margin | 52.9% | 15.7% |
| Operating Margin | -9.0% | -27.5% |
| Net Margin | -70.9% | -26.8% |
| Revenue YoY | 8.1% | -11.8% |
| Net Profit YoY | -557.1% | -2813.2% |
| EPS (diluted) | — | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $88.0M | ||
| Q3 25 | $52.3M | $92.6M | ||
| Q2 25 | $45.6M | $93.5M | ||
| Q1 25 | $41.5M | $97.3M | ||
| Q4 24 | $57.5M | $99.8M | ||
| Q3 24 | $51.5M | $99.2M | ||
| Q2 24 | $46.6M | $93.0M | ||
| Q1 24 | $44.9M | $86.2M |
| Q4 25 | $-44.1M | $-23.6M | ||
| Q3 25 | $-5.5M | $758.0K | ||
| Q2 25 | $-5.6M | $3.9M | ||
| Q1 25 | $-11.4M | $3.3M | ||
| Q4 24 | $9.6M | $-809.0K | ||
| Q3 24 | $941.0K | $165.0K | ||
| Q2 24 | $-10.4M | $-4.1M | ||
| Q1 24 | $-6.2M | $-1.4M |
| Q4 25 | 52.9% | 15.7% | ||
| Q3 25 | 52.7% | 37.3% | ||
| Q2 25 | 52.3% | 40.4% | ||
| Q1 25 | 48.6% | 38.7% | ||
| Q4 24 | 58.5% | 38.8% | ||
| Q3 24 | 56.3% | 38.7% | ||
| Q2 24 | 54.6% | 38.3% | ||
| Q1 24 | 51.3% | 37.0% |
| Q4 25 | -9.0% | -27.5% | ||
| Q3 25 | -17.6% | 0.3% | ||
| Q2 25 | -23.3% | 3.1% | ||
| Q1 25 | -36.1% | 2.6% | ||
| Q4 24 | 5.2% | -1.0% | ||
| Q3 24 | -8.2% | 0.1% | ||
| Q2 24 | -18.3% | -4.3% | ||
| Q1 24 | -23.9% | -1.5% |
| Q4 25 | -70.9% | -26.8% | ||
| Q3 25 | -10.5% | 0.8% | ||
| Q2 25 | -12.2% | 4.1% | ||
| Q1 25 | -27.5% | 3.3% | ||
| Q4 24 | 16.8% | -0.8% | ||
| Q3 24 | 1.8% | 0.2% | ||
| Q2 24 | -22.4% | -4.4% | ||
| Q1 24 | -13.8% | -1.6% |
| Q4 25 | — | $-0.21 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $0.00 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $89.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $169.7M |
| Total Assets | $461.5M | $225.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $89.6M | ||
| Q3 25 | $93.3M | $71.5M | ||
| Q2 25 | $75.5M | $72.1M | ||
| Q1 25 | $95.3M | $72.8M | ||
| Q4 24 | $98.7M | $75.4M | ||
| Q3 24 | $162.3M | $53.4M | ||
| Q2 24 | $177.9M | $36.6M | ||
| Q1 24 | $168.8M | $33.6M |
| Q4 25 | $341.7M | $169.7M | ||
| Q3 25 | $378.6M | $190.2M | ||
| Q2 25 | $377.6M | $187.0M | ||
| Q1 25 | $379.6M | $180.4M | ||
| Q4 24 | $395.7M | $174.3M | ||
| Q3 24 | $385.5M | $133.9M | ||
| Q2 24 | $389.1M | $129.7M | ||
| Q1 24 | $392.6M | $124.8M |
| Q4 25 | $461.5M | $225.4M | ||
| Q3 25 | $494.9M | $241.5M | ||
| Q2 25 | $493.3M | $249.0M | ||
| Q1 25 | $482.6M | $265.3M | ||
| Q4 24 | $499.5M | $247.4M | ||
| Q3 24 | $491.2M | $209.2M | ||
| Q2 24 | $483.7M | $200.2M | ||
| Q1 24 | $492.1M | $198.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $19.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $18.1M |
| FCF MarginFCF / Revenue | -2.9% | 20.5% |
| Capex IntensityCapex / Revenue | 1.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $19.3M | ||
| Q3 25 | $-3.9M | $-504.0K | ||
| Q2 25 | $108.0K | $-745.0K | ||
| Q1 25 | $-125.0K | $-2.9M | ||
| Q4 24 | $2.0M | $-16.8M | ||
| Q3 24 | $13.2M | $15.1M | ||
| Q2 24 | $6.2M | $2.9M | ||
| Q1 24 | $4.0M | $336.0K |
| Q4 25 | $-1.8M | $18.1M | ||
| Q3 25 | $-4.6M | $-624.0K | ||
| Q2 25 | $-1.5M | $-826.0K | ||
| Q1 25 | $-974.0K | $-3.0M | ||
| Q4 24 | $1.1M | $-17.2M | ||
| Q3 24 | $12.2M | $15.0M | ||
| Q2 24 | $5.2M | $2.9M | ||
| Q1 24 | $3.4M | $260.0K |
| Q4 25 | -2.9% | 20.5% | ||
| Q3 25 | -8.7% | -0.7% | ||
| Q2 25 | -3.2% | -0.9% | ||
| Q1 25 | -2.3% | -3.1% | ||
| Q4 24 | 1.9% | -17.2% | ||
| Q3 24 | 23.7% | 15.1% | ||
| Q2 24 | 11.0% | 3.1% | ||
| Q1 24 | 7.6% | 0.3% |
| Q4 25 | 1.6% | 1.4% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.3% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.19× | ||
| Q1 25 | — | -0.90× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 91.42× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
HNST
Segment breakdown not available.
